Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study.

Marousa Kouvela Maria Effrosyni LivanouDimitra T StefanouIoannis A VathiotisFotini SarropoulouMaria Grammoustianou Evangelos Dimakakos Nikolaos K Syrigos

Published in: Cancers (2024)

Thromboprophylaxis with an intermediate Tinzaparin dose in high thrombotic-risk lung cancer patients is a safe and effective choice for the prevention of VTE.

Keyphrases

venous thromboembolism
direct oral anticoagulants
atrial fibrillation
cross sectional
decision making